Radionetics Oncology
Greg Reinhart is currently working as the Principal Scientist at Radionetics Oncology, focusing on in vitro pharmacology. With previous experience as a Senior Scientist at Crinetics Pharmaceuticals and Scientist I at Receptos, Inc., as well as a background in molecular biology and assay development, Greg has a strong foundation in drug discovery and program support. They possess a Bachelor's degree in General Biology from San Diego State University.